These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38319381)

  • 1. Antibiotic susceptibility in Endophthalmitis Management Study and intravitreal antibiotic practice trend in India-EMS Report #5.
    Das T; Pandey S; Joseph J; Sheth J; Belenje A; Behera UC; Kapoor A; Pandya R; Dave VP
    Graefes Arch Clin Exp Ophthalmol; 2024 Jul; 262(7):2163-2169. PubMed ID: 38319381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of bacterial isolates to vancomycin and ceftazidime from patients with endophthalmitis: Is there a need to change the empirical therapy in suspected bacterial endophthalmitis?
    Reddy AK; Reddy RR; Paruvelli MR; Ambatipudi S; Rani A; Lodhi SA; Reddy JM; Reddy KR; Pandey N; Videkar R; Sinha MK; Majji AB; Deb-Jorder N; Sahu AK; Myneni J; Abraham A
    Int Ophthalmol; 2015 Feb; 35(1):37-42. PubMed ID: 25384628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the utility of inflammation score in post-cataract surgery endophthalmitis. Results from a prospective study in India. EMS Report #4.
    Das T; Belenje A; Joseph J; Pandey S; Behera U; Dave VP;
    Indian J Ophthalmol; 2024 Jan; 72(1):81-86. PubMed ID: 38131575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentations, risk factors and outcomes of ceftazidime-resistant Gram-negative endophthalmitis.
    Dave VP; Pathengay A; Nishant K; Pappuru RR; Sharma S; Sharma P; Narayanan R; Jalali S; Mathai A; Das T
    Clin Exp Ophthalmol; 2017 Apr; 45(3):254-260. PubMed ID: 27616274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endophthalmitis Management Study-A Prospective Randomized Clinical Trial on Postoperative Endophthalmitis Management in India: An Interim Analysis. Endophthalmitis Management Study Report #3.
    Das T; Belenje A; Pandey S; Behera UC; Joseph J; Dave VP;
    Asia Pac J Ophthalmol (Phila); 2023 Sep-Oct 01; 12(5):437-443. PubMed ID: 37851560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistently Vitreous Culture-Positive Exogenous Bacterial Endophthalmitis.
    Leung EH; Kuriyan AE; Flynn HW; Miller D; Huang LC
    Am J Ophthalmol; 2016 May; 165():16-22. PubMed ID: 26921804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of bacterial endophthalmitis isolates to vancomycin, ceftazidime, and amikacin.
    Chen KJ; Sun MH; Hou CH; Chen HC; Chen YP; Wang NK; Liu L; Wu WC; Chou HD; Kang EY; Lai CC
    Sci Rep; 2021 Aug; 11(1):15878. PubMed ID: 34354181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Nine-Year Analysis of Practice Patterns, Microbiologic Yield, and Clinical Outcomes in Cases of Presumed Infectious Endophthalmitis.
    Feng HL; Robbins CB; Fekrat S
    Ophthalmol Retina; 2020 Jun; 4(6):555-559. PubMed ID: 32387054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiological Isolates and Antibiotic Susceptibilities: A 10-Year Review of Culture-Proven Endophthalmitis Cases.
    Liu C; Ji J; Li S; Wang Z; Tang L; Cao W; Sun X
    Curr Eye Res; 2017 Mar; 42(3):443-447. PubMed ID: 27347700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and microbiologic review of culture-proven endophthalmitis caused by multidrug-resistant bacteria in patients seen at a tertiary eye care center in southern India.
    Pathengay A; Moreker MR; Puthussery R; Ambatipudi S; Jalali S; Majji AB; Mathai A; Husssain N; Dave V; Sharma S; Das T
    Retina; 2011 Oct; 31(9):1806-11. PubMed ID: 21478803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal triple therapy with vancomycin, ceftazidime, and moxifloxacin for bacterial endophthalmitis: A Twelve-year experience.
    Taubenslag KJ; Cherney EF; Patel SN; Law JC; Daniels AB; Kim SJ
    Graefes Arch Clin Exp Ophthalmol; 2023 Oct; 261(10):2813-2819. PubMed ID: 37227476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features, microbiological profile and treatment outcome of patients with Corynebacterium endophthalmitis: review of a decade from a tertiary eye care centre in southern India.
    Joseph J; Nirmalkar K; Mathai A; Sharma S
    Br J Ophthalmol; 2016 Feb; 100(2):189-94. PubMed ID: 26124461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-Traumatic Endophthalmitis: Clinico-Microbiological Profile, Antimicrobial Susceptibility and Prognostic Factors at a Tertiary Eye Care Centre in Eastern India.
    Mitra S; Agarwal T; Naik A; Padhi TR; Basu S; Behera UC
    Semin Ophthalmol; 2021 Nov; 36(8):742-750. PubMed ID: 33750256
    [No Abstract]   [Full Text] [Related]  

  • 14. Microbiologic spectrum and susceptibility of isolates: part II. Posttraumatic endophthalmitis. Endophthalmitis Research Group.
    Kunimoto DY; Das T; Sharma S; Jalali S; Majji AB; Gopinathan U; Athmanathan S; Rao TN
    Am J Ophthalmol; 1999 Aug; 128(2):242-4. PubMed ID: 10458188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endophthalmitis caused by streptococcal species: clinical settings, microbiology, management, and outcomes.
    Kuriyan AE; Weiss KD; Flynn HW; Smiddy WE; Berrocal AM; Albini TA; Miller D
    Am J Ophthalmol; 2014 Apr; 157(4):774-780.e1. PubMed ID: 24418264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection.
    Storey P; Dollin M; Pitcher J; Reddy S; Vojtko J; Vander J; Hsu J; Garg SJ;
    Ophthalmology; 2014 Jan; 121(1):283-289. PubMed ID: 24144453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiologic spectrum and susceptibility of isolates: part I. Postoperative endophthalmitis. Endophthalmitis Research Group.
    Kunimoto DY; Das T; Sharma S; Jalali S; Majji AB; Gopinathan U; Athmanathan S; Rao TN
    Am J Ophthalmol; 1999 Aug; 128(2):240-2. PubMed ID: 10458187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiological spectrum and antibiotic sensitivity in endophthalmitis: a 25-year review.
    Gentile RC; Shukla S; Shah M; Ritterband DC; Engelbert M; Davis A; Hu DN
    Ophthalmology; 2014 Aug; 121(8):1634-42. PubMed ID: 24702755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative intravitreal antibiotic therapy for experimental Enterococcus faecalis endophthalmitis.
    Choi S; Hahn TW; Osterhout G; O'Brien TP
    Arch Ophthalmol; 1996 Jan; 114(1):61-5. PubMed ID: 8540852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of aetiological agents of postoperative endophthalmitis and antibiotic susceptibility of bacterial isolates.
    Anand AR; Therese KL; Madhavan HN
    Indian J Ophthalmol; 2000 Jun; 48(2):123-8. PubMed ID: 11116508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.